I'm not sure what people expect.  They are doing a bunch of clinical trials, all externally funded if I recall.  We have to wait until one or more are successful and at the stage where a pharma (hopefully) will pull the trigger. 

There's nothing else management can do except some funding to keep the lights on.  The trading on the OTC doesn't make raising cash any easier.

I don't like the wait any more than all y'all but that's the reality of this investment.